CLINICAL TRIALS PROFILE FOR MASOPROCOL
✉ Email this page to a colleague
All Clinical Trials for MASOPROCOL
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00313534 ↗ | Nordihydroguaiaretic Acid in Treating Patients With Nonmetastatic Relapsed Prostate Cancer | Terminated | National Cancer Institute (NCI) | Phase 1 | 2005-06-01 | RATIONALE: Nordihydroguaiaretic acid may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase I trial is studying the side effects and best dose of nordihydroguaiaretic acid in treating patients with nonmetastatic relapsed prostate cancer. |
NCT00313534 ↗ | Nordihydroguaiaretic Acid in Treating Patients With Nonmetastatic Relapsed Prostate Cancer | Terminated | University of California, San Francisco | Phase 1 | 2005-06-01 | RATIONALE: Nordihydroguaiaretic acid may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase I trial is studying the side effects and best dose of nordihydroguaiaretic acid in treating patients with nonmetastatic relapsed prostate cancer. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for MASOPROCOL
Condition Name
Clinical Trial Locations for MASOPROCOL
Trials by Country
Clinical Trial Progress for MASOPROCOL
Clinical Trial Phase
Clinical Trial Sponsors for MASOPROCOL
Sponsor Name